JAY T FLATLEY
CIK 1189130 · Chairman and Acting CEO · last filed 2026-06-05
JAY T FLATLEY is a Chairman and Acting CEO who has filed 353 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for DNLI, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$492.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $35.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$35.34M
6
353
-$491.98M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNLI | Director | 358,941 | $21.66 | $7.77M | $0 | 12 | 2026-06-05 |
| RIVN | Director | 160,820 | $16.76 | $2.70M | $2.75M | 7 | 2026-03-05 |
| Zymergen Inc. (ZY) Delisted | Chairman and Acting CEO | 0 | $2.43 | $0 | $1.00M | 4 | 2022-10-19 |
| COHR | Director | 856 | $385.03 | $329.6K | -$2.07M | 22 | 2022-07-01 |
| ILMN | Director | 152,433 | $160.97 | $24.54M | -$494.38M | 303 | 2021-05-20 |
| Juno Therapeutics, Inc. (JUNO) Delisted | Director | 0 | — | — | $724.4K | 5 | 2018-03-07 |
Recent Filings
353 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | DNLI | Grant (A) | +6,408 | $0 | EDGAR |
| 2026-03-05 | RIVN | Mixed | +1,250 | $13.5K | EDGAR |
| 2025-06-20 | RIVN | Grant (A) | +16,812 | $0 | EDGAR |
| 2025-06-05 | DNLI | Grant (A) | +6,037 | $0 | EDGAR |
| 2024-06-21 | RIVN | Grant (A) | +24,224 | $0 | EDGAR |
| 2024-06-04 | DNLI | Grant (A) | +5,967 | $0 | EDGAR |
| 2023-06-23 | RIVN | Grant (A) | +18,208 | $0 | EDGAR |
| 2023-06-05 | DNLI | Grant (A) | +4,216 | $0 | EDGAR |
| 2022-10-19 | Zymergen Inc. (ZY) Delisted | Disp (D) | −144,789 | $0 | EDGAR |
| 2022-07-01 | COHR | Disp (D) | −43,018 | $0 | EDGAR |